Envista Holdings Corporation header image

Envista Holdings Corporation

NVST

Equity

ISIN US29415F1049 / Valor 49153522

New York Stock Exchange, Inc (2024-09-18)
USD 19.18+0.95%

Envista Holdings Corporation
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Envista Holdings Corporation is a global company that develops and manufactures a wide range of dental products, equipment, and consumable supplies for dental offices. The company's Specialty Products & Technologies division focuses on dental implant systems, prosthetics, clear aligners, orthodontic products, and lab supplies, while the Equipment & Consumables segment produces digital imaging systems, endodontic systems, restorative materials, and infection prevention products. With a portfolio of over 30 trusted dental brands, Envista aims to partner with professionals to enhance patient care through innovative products, solutions, and technology. The company is dedicated to supporting dental professionals with quality products, integrated digital workflows, and comprehensive training programs for professional growth.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Sales Performance

Envista Holdings Corporation reported sales of $623.6 million for the first quarter of 2024, reflecting a slight decrease from the $627.2 million reported in the same quarter of 2023. Core sales in the quarter saw a modest increase of 0.4% compared to the corresponding quarter in the previous year.

Net Income

For the first quarter of 2024, Envista Holdings Corporation achieved a net income of $23.6 million, or $0.14 per diluted share. This represents a significant decline from the net income of $43.8 million, or $0.25 per diluted share, reported in the first quarter of 2023.

Adjusted Net Income

Envista Holdings Corporation's adjusted net income for the first quarter of 2024 was $45.8 million, or $0.26 per diluted share. This is a decrease from the adjusted net income of $67.8 million, or $0.38 per diluted share, recorded in the same period of the previous year.

Adjusted EBITDA

In the first quarter of 2024, Envista Holdings Corporation reported an adjusted EBITDA of $87.2 million. This is a decline from the adjusted EBITDA of $114.0 million reported in the first quarter of 2023, indicating a challenging quarter for the company.

CEO Commentary

Amir Aghdaei, Chief Executive Officer of Envista Holdings Corporation, acknowledged the challenging first quarter of 2024 but highlighted the company's focus on long-term investments to drive growth and profitability. He noted progress in the Spark business and the stabilization of the consumables business, while also emphasizing the strategic priorities for the remainder of the year.

Summarized from source with an LLMView Source

Key figures

-33.6%1Y
-54.9%3Y
-31.4%5Y

Performance

37.0%1Y
33.6%3Y
39.8%5Y

Volatility

Market cap

3298 M

Market cap (USD)

Daily traded volume (Shares)

574,405

Daily traded volume (Shares)

1 day high/low

19.74 / 18.87

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.49%USD 32.16
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.65%USD 2.62
Merit Medical Systems Inc
Merit Medical Systems Inc Merit Medical Systems Inc Valor: 951136
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%USD 98.71
Premier Inc
Premier Inc Premier Inc Valor: 22227168
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%USD 20.48
Lantheus Holdings Inc
Lantheus Holdings Inc Lantheus Holdings Inc Valor: 24784644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.46%USD 108.14
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.85%USD 20.78
Evotec SE
Evotec SE Evotec SE Valor: 3979578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 3.64
Inter Parfums Inc
Inter Parfums Inc Inter Parfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.87%USD 118.88
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.45%USD 31.39
Hutchmed (China) Limited
Hutchmed (China) Limited Hutchmed (China) Limited Valor: 30165904
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 16.32